
|Articles|December 1, 2004
IVAX markets generic version of Alphagan
IVAX Corp. joins the growing number of drug manufacturers to market its version of brimonidine tartrate ophthalmic solution 0.2%.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Physician perspective: Glaucoma eye drops are here to stay
2
Commercial red light devices for myopia may exceed safety limits
3
No significant visual gains seen with PDE6A gene supplementation in early-phase trial
4
SparingVision completes PRODYGY trial patient dosing with SPVN06
5




























